Activity Overview
This online, on-demand virtual symposium is presented by a renowned expert in muscular dystrophies. In this educational program, this expert will discuss the diagnosis and management of muscular dystrophies, with a focus on Duchenne Muscular Dystrophy.
This educational activity is an archive of the live virtual symposium held on September 19, 2026.
Target Audience
This activity is intended for neuromuscular specialists, neurologists, nurse practitioners, physician assistants, and nurses who treat neuromuscular diseases.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Implement guideline recommendations to diagnose patients with suspected Duchenne muscular dystrophy
- Integrate appropriate therapies into holistic management plans for patients with DMD/BMD
- Formulate multidisciplinary treatment plans for patients with Duchenne muscular dystrophy
Katherine Mathews, MD
Robert and JoAnn Jensen Chair in Pediatric Neurology
Professor of Pediatrics and Neurology
Director, Iowa Neuromuscular Program
Director, Muscular Dystrophy Clinic
Vice Chair for Clinical Research, Department of Pediatrics
University of Iowa Health Care
Iowa City, IA
Disclosures: Advisor, Consultant, Fee for Service Recipient: AskBio, Edgewise Therapeutics, ML Bio, Sarepta Therapeutics; Grant/Research Funding: AMO Pharma, AskBio, Avidity, Biohaven, Capricor, FibroGen, Italfarmaco, Larimar, ML Bio, Novartis, PTC Therapeutics, Reata Pharmaceuticals, Sarepta Therapeutics, Scholar Rock; Other (Data and Safety Monitoring Board): Dyne Therapeutics, Solid Biosciences.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.
This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.
The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.